Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI)

References

• Chua TC, Moran BJ, Sugarbaker PH, et al. (2012). Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–56.
   PubMed Web of Science ®Google Scholar
• Yan TD, Black D, Savady R, Sugarbaker PH. (2007). A systematic review on efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14:484–92.
   PubMed Web of Science ®Google Scholar
• Yan TD, Deraco M, Baratti D, et al. (2009). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–42.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Elias D, Baratti D, et al. (2008). Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98:263–7.
   PubMed Web of Science ®Google Scholar
• Morgan RJ, Jr, Armstrong DK, Alvarez RD, et al. (2016). Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14:1134–63.
   PubMed Web of Science ®Google Scholar
• Le Brun JF, Campion L, Berton-Rigaud D, et al. (2014). Survival benefit of intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study. Ann Surg Oncol 21:3621–7.
   PubMed Web of Science ®Google Scholar
• Bakrin N, Bereder JM, Decullier E, et al. (2013). Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39:1435–43.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Verheij M, Allum W, et al. (2016). ESMO Guidelines Committee. Gastric Cancer: ESMO Clinical Practice Guidelines. Ann Oncol 27:v38–49.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Huang CQ, Suo T, et al. (2011). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18:1575–81.
   PubMed Web of Science ®Google Scholar
• Glehen O, Gilly FN, Arvieux C, et al. (2010). Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370–7.
   PubMed Web of Science ®Google Scholar
• Chia CS, You B, Decullier E, et al. (2016). Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23:1971–9.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Canbay E, Li Y, et al. (2016). A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol 42:1123–31.
   PubMed Web of Science ®Google Scholar
• Honoré C, Goéré D, Macovei R, et al. (2016). Peritoneal carcinomatosis from unusual cancer origins: is there a role for hyperthermic intraperitoneal chemotherapy? J Visc Surg 153:101–7.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. (1996). Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15:49–58.
   Web of Science ®Google Scholar
• Sugarbaker PH. (1996). Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy. Cancer Treat Res 81:149–68.
   PubMedGoogle Scholar
• Elias D, Antoun S, Goharin A, et al. (2000). Research on the best chemohyperthermia technique for treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig 1:431–9.
   PubMedGoogle Scholar
• Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2010. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14.
   Google Scholar
• Spratt JS, Adcock RA, Sherrill W, Travathen S. (1980). Hyperthermic peritoneal perfusion system in canines. Cancer Res 40:253–5.
   PubMed Web of Science ®Google Scholar
• Chua TC, Saxena A, Schellekens JF, et al. (2010). Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg 251:101–6.
   PubMed Web of Science ®Google Scholar
• Glehen O, Osinsky D, Cotte E, et al. (2003). Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–9.
   PubMed Web of Science ®Google Scholar
• Kwakman R, Schrama AM, van Olmen JP, et al. (2016). Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases a meta-analysis. Ann Surg 263:1102–11.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. (2003). Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis from colorectal cancer. J Clin Oncol 21:3737–43.
   PubMed Web of Science ®Google Scholar
• Elias D, Lefevre JH, Chevalier J, et al. (2009). Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–5.
   PubMed Web of Science ®Google Scholar
• Elias D, Gilly F, Boutitie F, et al. (2010). Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–8.
   PubMed Web of Science ®Google Scholar
• Goéré D, Malka D, Tzanis D, et al. (2013). Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257:1065–71.
   PubMed Web of Science ®Google Scholar
• de Cuba EM, Kwakman R, Knol DL, et al. (2013). Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 39:321–7.
   PubMed Web of Science ®Google Scholar
• Gomes da Silva RG, Sugarbaker PH. (2006). Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203:878–86.
   PubMed Web of Science ®Google Scholar
• Cotte E, Passot G, Gilly FN, Glehen O. (2010). Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2:31–5.
   PubMed Web of Science ®Google Scholar
• Cashin PH, Graf W, Nygren P, Mahteme H. (2012). Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study. Ann Surg 256:1078–83.
   PubMed Web of Science ®Google Scholar
• Goéré D, Souadka A, Faron M, et al. (2015). Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 22:2958–64.
   PubMed Web of Science ®Google Scholar
• Gurumurthy M, Bryant A, Shanbhag S. (2014). Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent). Cochrane Database Syst Rev 21:CD006912.
   Google Scholar
• Hauspy J, Beiner ME, Harley I, et al. (2011). Role of adjuvant radiotherapy in granulosa cell tumors of the ovary. Int J Radiation Oncol, Biol, Phys 79:770–4.
   PubMed Web of Science ®Google Scholar
• Mangili G, Ottolina J, Gadducci A, et al. (2013). Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer 109:29–34.
   PubMed Web of Science ®Google Scholar
• Sun H-D, Lin H, Jao MS, et al. (2012). A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 124:244–9.
   PubMed Web of Science ®Google Scholar
• Gouy S, Uzan C, Pautier P, et al. (2013). Results of oxaliplatin-based hyperthermic intraperitoneal chemotherapy in recurrent ovarian granulosa cell tumors. Eur J Obstet Gynecol Reprod Biol 170:464–7.
   PubMed Web of Science ®Google Scholar
• Al-Badawi IA, Abu-Zaid A, Azzam A, et al. (2014). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of recurrent/relapsed ovarian granulosa cell tumor: a single-center experience. J Obstet Gynaecol Res 40:2066–75.
   PubMed Web of Science ®Google Scholar
• Norlén O, Stålberg P, Öberg K, et al. (2012). Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg 36:1419–31.
   PubMed Web of Science ®Google Scholar
• Norlén O, Edfeldt K, Akerstrom G, et al. (2014). Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: clinical course and genetic profiling. Surgery 156:1512–21.
   PubMed Web of Science ®Google Scholar
• Boudreaux JP, Wang YZ, Diebold AE, et al. (2014). A single institution's experience with surgical cytoreduction of stage IV, well-differentiated, small bowel neuroendocrine tumors. J Am Coll Surg 218:837–4.
   PubMed Web of Science ®Google Scholar
• Pavel M, O'Toole D, Costa F, et al. (2016). ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology 103:172–85.
   PubMed Web of Science ®Google Scholar
• Kianmanesh R, Ruszniewski P, Rindi G, et al. (2010). ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. Neuroendocrinology 91:333–40.
   PubMed Web of Science ®Google Scholar
• Elias D, Sideris L, Liberale G, et al. (2005). Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas. Surgery 137:411–6.
   PubMed Web of Science ®Google Scholar
• Elias D, David A, Sourrouille I, et al. (2014). Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases). Surgery 155:5–12.
   PubMed Web of Science ®Google Scholar
• de Mestier L, Lardière-Deguelte S, Brixi H, et al. (2015). Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors. Neuroendocrinology 101:105–11.
   PubMed Web of Science ®Google Scholar
• Jaques DP, Coit DG, Hajdu SI, Brennan MF. (1990). Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 212:51–9.
   PubMed Web of Science ®Google Scholar
• Rossi CR, Deraco M, De Simone M, et al. (2004). Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 100:1943–50.
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Cavalcanti A, Le Péchoux C, et al. (2005). Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 31:917–23.
   PubMed Web of Science ®Google Scholar
• Barratti D, Pennacchioli E, Kusamura S, et al. (2010). Peritoneal sar-comatosis: is there a subset of patients who may benefitfrom cytoreductive surgery and hyperthermic intraperitonealchemotherapy? Ann Surg Oncol 17:3220–8.
   PubMed Web of Science ®Google Scholar
• Baumgartner JM, Ahrendt SA, Pingpank JF, et al. (2013). Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol 107:329–34.
   PubMed Web of Science ®Google Scholar
• Sarnaik AA, Sussman JJ, Ahmad SA, et al. (2007). Technology for the delivery of hyperthermic intraoperative intraperitoneal chemotherapy: a survey of techniques. Recent Results Cancer Res 169:75–82.
   PubMedGoogle Scholar
• Ortega-Deballon P, Facy O, Jambet S, et al. (2010). Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol 17:1957–63.
   PubMed Web of Science ®Google Scholar
• Systemic chemotherapy with or without intraperitoneal chemohyperthermia in treating patients undergoing surgery for peritoneal carcinomatosis from colorectal cancer. Available from: https://clinicaltrials.gov/show/NCT00769405.
   Google Scholar